SCHEMBL29529482

SCHEMBL29529482

Cc1cc2c(Oc3ccc(N(C(=O)C4(C(N)=O)CC4)c4ccc(F)cc4)cc3)ccnc2cc1C=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AXL P30530 18/20 0.51
MET P08581 13/20 0.51
MERTK Q12866 8/20 0.49
AURKA O14965 1/20 0.49
RIPK2 O43353 1/20 0.49
ABCB11 O95342 1/20 0.49
ABL1 P00519 1/20 0.49
EGFR P00533 1/20 0.49
ERBB2 P04626 1/20 0.49
NTRK1 P04629 1/20 0.49
LCK P06239 1/20 0.49
PGR P06401 1/20 0.49
LYN P07948 1/20 0.49
RET P07949 1/20 0.49
CHRM2 P08172 1/20 0.49
HCK P08631 1/20 0.49
ADRA2A P08913 1/20 0.49
ADORA3 P0DMS8 1/20 0.49
KIT P10721 1/20 0.49
CHRM1 P11229 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22749975 1.00 AXL (0.51) AXLMETMERTKAURKARIPK2
SCHEMBL22749991 0.93 AXL (0.50) AXLMETMERTKAURKARIPK2
SCHEMBL29529324 0.93 AXL (0.50) AXLMETMERTKAURKARIPK2
SCHEMBL21200779 0.90 AXL (0.56) AXLMETMERTKAURKARIPK2
SCHEMBL30616283 0.90 AXL (0.56) AXLMETMERTKAURKARIPK2
SCHEMBL29529447 0.87 AXL (0.50) AXLMETMERTKAURKARIPK2
SCHEMBL21201097 0.87 AXL (0.50) AXLMETMERTKAURKARIPK2
SCHEMBL372017 0.86 MET (0.66) AXLMETMERTKAURKARIPK2
SCHEMBL29883010 0.86 MET (0.66) AXLMETMERTKAURKARIPK2
SCHEMBL21201265 0.84 AXL (0.54) AXLMETMERTKAURKARIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3980404-A1 COMPOUNDS FOR THE TREATMENT OF KINASE-DEPENDENT DISORDERS Exelixis, Inc. (US) 2022-04-13 EP disclosed